Cellebrite: Mobile Forensics Leadership At A Compelling Valuation
Cellebrite DI Ltd. 2026 Q2 - Results - Earnings Call Presentation
Lake Street Maintains Buy on Cellebrite DI, Lowers Price Target to $15
Cellebrite DI (CLBT) Cuts Guidance And Changes CEO, Is The Stock Now Cheap?
JP Morgan Maintains Overweight on Cellebrite DI, Lowers Price Target to $16
DA Davidson Maintains Buy on Cellebrite DI, Lowers Price Target to $15
Does Cellebrite DI’s Lowered 2026 Outlook and New CEO Reset Its AI Narrative (CLBT)?
Needham Maintains Buy on Cellebrite DI, Lowers Price Target to $12.5
Cellebrite DI (CLBT) Names Shiven Ramji As Next CEO
Cellebrite DI Ltd. Q2 2026 Earnings Call Summary
Cellebrite DI Ltd (CLBT) (Q2 2026) Earnings Call Highlights: ARR Misses Guidance, Full-Year ...
Cellebrite DI Ltd. (CLBT) Q2 2026 Earnings Call Transcript
Cellebrite Q2: This 33% Selloff Looks Like An Overreaction
Cellebrite DI Q2 Earnings Call Highlights
Cellebrite Shares Plunge Thursday: What's Driving the Move?
Cellebrite DI Ltd. (CLBT) Q2 Earnings and Revenues Miss Estimates
Full Transcript: Cellebrite DI Q2 2026 Earnings Call
Cellebrite DI Lowers FY2026 Sales Guidance from $565.000M-$571.000M to $555.000M-$561.000M vs $568.048M Est
Cellebrite DI Sees Q3 Sales $145.000M-$148.000M vs $150.298M Est
Cellebrite DI Q2 Adj. EPS $0.11, Inline, Sales $131.138M Miss $131.874M Estimate
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.